vendredi 22 août 2014

What I will and will not miss

Won't miss:



MNK's timing. For example, having boxes of medsaway pouches because we got them after the pain management focus. I couldn't give them away to the surgeons.



Looking around at my colleague's faces as we are at a meeting being told that pain management physicians would be our XXR focus! And then seeing my new territory and seeing long time pain physicians GONE. Pain docs? They couldn't use it for breakthrough and wouldn't use it chronically. Your marketing research must have included some old, broken down pain docs that wanted a fast buck.



Management not listening to the field and have advisory councils that are shams. Everyone is so afraid of the new guard that no rep was comfortable telling the truth.



Launching a drug with the deck stacked against you.



Taking family time to do expense reports, DM busy work reports, AND looking up and correcting target lists! How many times can I tell you this doc has moved?



Being held to a performance standard when the way to measure the performance is WRONG and slow. And losing my job because of it.



Hearing "Mallinwhat? How do you spell that?"



"What a stupid name for a drug."



Hearing "The doctor doesn't see reps...and no, we don't do lunches"



Hearing "I try not to use anything with APAP in it anymore, what was your company thinking?"



Being yelled at because a doc had to change a script because of something totally out of my control.



AND THE BEST: Watching a company NOT giving struggling reps a very valuable asset that could give them some leverage with some doctors, but giving the asset to reps who don't need the help. Should have been a set amount to all. Dumbest maneuver that I have ever seen in my years in pharma, and when I started looking for a job.



Will miss:



A great group of wonderful, professional reps who I had a lot of fun with during my tenure with MNK. I hope that whatever the future brings to you all, that you are happy.





What I will and will not miss

Aucun commentaire:

Enregistrer un commentaire